Shares of GlaxoSmithKline plc (ADR) (NYSE:GSK) ended Wednesday session in red amid volatile trading. The shares closed down -0.11 points or -0.25% at $43.33 with 2.09 million shares getting traded. Post opening the session at $43.33, the shares hit an intraday low of $43.20 and an intraday high of $43.44 and the price vacillated in this range throughout the day. The company has a market cap of $106.46 billion and the numbers of outstanding shares have been calculated to be 4.87 billion shares.
GlaxoSmithKline plc (ADR) (GSK) discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV.
Shares of Novavax, Inc. (NASDAQ:NVAX) ended Wednesday session in green amid volatile trading. The shares closed up +0.01 points or 0.50% at $2.01 with 13.62 million shares getting traded. Post opening the session at $1.99, the shares hit an intraday low of $1.96 and an intraday high of $2.06 and the price vacillated in this range throughout the day. The company has a market cap of $524.12 million and the numbers of outstanding shares have been calculated to be 271.19 million shares.
Novavax, Inc. (NVAX) announced it will host its 4th annual Investor and Analyst Meeting, Tuesday, October 11, 2016 from 9:00 a.m. – 11:00 a.m. ET in New York, NY.
Senior management will conduct a series of presentations to update analysts and investors on the Company`s ongoing clinical development programs.
For additional information and registration, please email firstname.lastname@example.org or call 443-213-0506.
A live webcast of the presentations can be accessed under the “Investors”/ “Events” section of the Novavax website at novavax.com. Please allow extra time prior to the webcast to visit the site and download the streaming media software required to listen to the Internet broadcast. The webcast and a replay of the presentation will also be accessible under the “Investors/Events” section of the Novavax website at novavax.com. The event will be archived on the company`s website for 90 days.